Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q3 EPS of ($1.17), $0.02 better than the analyst estimate of ($1.19).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.